P-27 Treatment with biphasic insulin aspart 30 improves glycaemic control in patients with Type 2 diabetes inadequately controlled with oral antidiabetic drugs: results from China cohort in the PRESENT study

Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results

Archives of Drug Information ◽

10.1111/j.1753-5174.2008.00015.x ◽

2009 ◽

Vol 2 (2) ◽

pp. 23-33 ◽

Cited By ~ 5

Author(s):

Serdar Güler ◽

Surendra Kumar Sharma ◽

Majeed Almustafa ◽

Chong Hwa Kim ◽

Sami Azar ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Aspart ◽

Oral Antidiabetic Drugs ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

Study Results ◽

Improved Glycaemic Control

PDB5 GLYCAEMIC CONTROL AND INSULIN UTILIZATION IN UK PATIENTS WITH TYPE 2 DIABETES INITIATED ON EITHER BIPHASIC INSULIN ASPART 30 OR BIPHASIC HUMAN INSULIN 30

Value in Health ◽

10.1016/s1098-3015(10)72252-x ◽

2010 ◽

Vol 13 (3) ◽

pp. A55 ◽

Cited By ~ 1

Author(s):

W Fakhoury ◽

H Richter ◽

T Christensen ◽

TL Thomsen ◽

D Irwin ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2019.02.023 ◽

2019 ◽

Vol 150 ◽

pp. 158-166 ◽

Cited By ~ 1

Author(s):

Wenying Yang ◽

Canan Ersoy ◽

Guixia Wang ◽

Shandong Ye ◽

Jun Liu ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Aspart ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

Adding biphasic insulin aspart 30 once or twice daily is more efficacious than optimizing oral antidiabetic treatment in patients with type 2 diabetes

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2007.00743.x ◽

2007 ◽

Vol 9 (5) ◽

pp. 724-732 ◽

Cited By ~ 21

Author(s):

W. M. W. Bebakar ◽

C. C. Chow ◽

K. A. Kadir ◽

S. Suwanwalaikorn ◽

J. A. Vaz ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Antidiabetic Treatment ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2007.00826.x ◽

2008 ◽

Vol 10 (3) ◽

pp. 212-222 ◽

Cited By ~ 34

Author(s):

D. Khutsoane ◽

S. K. Sharma ◽

M. Almustafa ◽

H. C. Jang ◽

S. T. Azar ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Practice ◽

Glycaemic Control ◽

Insulin Aspart ◽

Practice Setting ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Clinical Practice Setting

Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2008.00904.x ◽

2009 ◽

Vol 11 (1) ◽

pp. 33-40 ◽

Cited By ~ 12

Author(s):

Y. Gao ◽

X. H. Guo ◽

J. A. Vaz ◽

Keyword(s):

Type 2 Diabetes ◽

Clinical Practice ◽

Glycaemic Control ◽

Insulin Aspart ◽

Practice Setting ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Clinical Practice Setting

Switching from biphasic human insulin 30 to biphasic insulin aspart 30 in type 2 diabetes is associated with improved glycaemic control and a positive safety profile: Results from the A1chieve study

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2012.09.043 ◽

2012 ◽

Vol 98 (3) ◽

pp. 408-413 ◽

Cited By ~ 15

Author(s):

Nabil K. El Naggar ◽

Pradana Soewondo ◽

Mohammad E. Khamseh ◽

Jian-Wen Chen ◽

Jihad Haddad

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Human Insulin ◽

Safety Profile ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Improved Glycaemic Control

Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study

Diabetes & Metabolism Journal ◽

10.4093/dmj.2013.37.2.117 ◽

2013 ◽

Vol 37 (2) ◽

pp. 117 ◽

Cited By ~ 5

Author(s):

Kee-Ho Song ◽

Jung Min Kim ◽

Jung-Hyun Noh ◽

Yongsoo Park ◽

Hyun-Shik Son ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Efficacy And Safety ◽

Open Label ◽

Antidiabetic Therapy ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

Letter: Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study (Diabetes Metab J2013;37:117-24)

Diabetes & Metabolism Journal ◽

10.4093/dmj.2013.37.3.212 ◽

2013 ◽

Vol 37 (3) ◽

pp. 212

Author(s):

Byung-Wan Lee

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Efficacy And Safety ◽

Open Label ◽

Antidiabetic Therapy ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

Biphasic Insulin Aspart 30 (BIAsp 30) is Safe and Improves Glycaemic Control in Insulin Naïve Patients with Type 2 Diabetes

Journal of Diabetes & Metabolism ◽

10.4172/2155-6156.1000123 ◽

2012 ◽

Vol 02 (03) ◽

Author(s):

Alireza Esteghamati ◽

Manouchehr Nakhjavani

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽